Neuro Vigor licenses innovative Purdue technology to treat neurological diseases

April, 2014

WEST LAFAYETTE, Ind., – Neuro Vigor LLC announced today (April, 2014) the signing of an exclusive worldwide license with Purdue Research Foundation (PRF), to develop and commercialize technology which promises an innovative approach to treating neurological disease and injury, including multiple sclerosis, neuropathic pain and Parkinson’s disease.

This pioneering technology is based on over 15 years of research conducted by Neuro Vigor’s co-founder and chief scientist, Dr. Riyi Shi, an internationally recognized researcher and professor of biomedical engineering and neurosciences at Purdue University.

“We are pleased to have reached a license agreement with PRF to bring the benefits of this technology to patients worldwide,” said Dr. Shi. “This therapy offers strong potential to reduce symptoms with more effectiveness and fewer side-effects than current treatments.”

The PRF technology licensed by Neuro Vigor focuses on a novel way to reduce a toxic substance that Dr. Shi has identified as a significant contributor to neurological disease and pain. The company intends to pursue advanced pre-clinical research prior to the advent of clinical trials and eventual patient use.

The technology is patented through the Purdue Office of Technology Commercialization, which operates one of the most comprehensive technology transfer programs among leading research universities in the U.S.

About Neuro Vigor

Neuro Vigor is a privately held limited liability corporation headquartered in West Lafayette, Indiana.   The company was co-founded in 2013 by Dr. Riyi Shi and Mark Van Fleet, former Executive Director of Purdue’s Global Business Engagement initiative; and a senior executive with the U.S. Chamber of Commerce. Neuro Vigor is focused on the commercialization of therapeutics and diagnostics to address diseases and disorders of the human neurological system.   The company’s founding team also includes David Giddings, the former president & COO of Boehringer Mannheim Corp., a leading global medical and pharmaceutical firm; chairman, president and CEO of Diametrics Medical Inc.; and CEO of Digilab Inc.

Neuro Vigor contact: Mark Van Fleet, 765-430-5559

Purdue Research Foundation contact: Cynthia Sequin, 765-588-3340, casequin@prf.org